| MACKAY MEMORIAL HOSPITAL Patent applications |
| Patent application number | Title | Published |
|---|
| 20110220127 | Endotracheal Tube Holder - An endotracheal tube holder is provided. The endotracheal tube holder includes an adjustable securing clamp, an adjusting unit, a bite block, and a securing strap. The adjustable securing clamp includes a first clamping unit having a first clamping portion, and a second clamping unit having a second clamping portion. The first clamping portion and the second clamping portion are oppositely and correspondingly aligned for holding an endotracheal tube. The adjusting unit includes an elastic member, coupled between the first clamping unit and the second clamping unit. The bite block is configured at one side of the first clamping portion and includes an endotracheal tube accommodation portion. The endotracheal tube accommodation portion covers over the endotracheal tube for providing a protection to the endotracheal tube. The securing strap includes two ends respectively coupled to two lateral sides of the first clamping unit. | 09-15-2011 |
| 20110184315 | Multi-Loop Bridge-Type Apparatus for the Collection of Cells - A multi-loop bridge-type apparatus for the collection of cells is provided. The multi-loop bridge-type apparatus includes a barrel, a plunger, a filter unit, and at least two external ducts. The barrel includes one open end. The filter unit is disposed inside an inner space of the barrel and partitions the inner space of the barrel into a first space and a second space. The open end is structured for connection to the first space. The plunger is coupled with the barrel and is adapted for executing a piston motion along the second space. Each external duct has two ends respectively communicating with the first space and the second space. Each external duct further includes a control valve for controlling the duct to be conducted or shut off. | 07-28-2011 |
| 20110183918 | Method of Treating Leukemia Using Rcie Prolamin - The present invention relates to a method of treating leukemia using rice prolamin, and a pharmaceutical composition for treating leukemia, comprising an effective amount of rice prolamin together with one or more pharmaceutically acceptable carriers or excipients. For the treatment application, the rice prolamin can stimulate human peripheral blood mononuclear cell (PBMC) to produce cytokines, such as tumor necrosis factor-alpha, to inhibit growth of and induce differentiation of human leukemia U937 cells. The rice prolamin is gluten-free, thus will not trigger gastrointestinal allergic reaction. | 07-28-2011 |
| 20110054028 | SUPPLEMENT FOR REDUCING HIV TRANSMISSION AND METHOD THEREOF - There is an urgent need for a method to reduce the risk of mother-to-child transmission (MTCT) of HIV during breastfeeding in HIV pandemic regions. The present invention provides a supplement for reducing the chance of transmitting HIV during MTCT and method thereof. The supplement comprising arachidonic acid (AA) alone, or a mixture of AA and DHA at safe intake doses. The supplement is provided to either the breastfeeding mothers or the babies to maintain cell membrane potential polarization through activation of the background potassium channels, thereby reducing the risk of HIV transmission. | 03-03-2011 |
| 20090318400 | METHOD FOR INHIBITING TUMOR GROWTH WITH DEHYDROSULPHURENIC ACID EXTRACTED FROM ANTRODIA CINNAMOMEA - The present invention relates to a method for inhibiting tumor growth, in particular to the method using dehydrosulphurenic acid to inhibit the growth of leukemia cell or pancreatic cancer cell by a compound extracted and purified from | 12-24-2009 |
| 20090082437 | Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer - The present invention relates to a method for enhancing radiosensitivity in radiotherapy of cervical cancer by administering to cervical cancer cells an effective amount of oxaliplatin. Radiation combined with pretreatment of oxaliplatin according to the present invention helps to enhance the cytotoxicity of radiation and result in augmenting radiation-induced mitotic catastrophe. The analysis on molecular mechanism revealed that oxaliplatin augmented the radiation-induced DNA double-strand break indicated by reducing gamma-H2AX expression, abrogated radiation-induced ATM phosphorylation and reduced the Chk2 phosphorylation. Oxaliplatin can be used as a promising radiosensitizer for treatment of cervical cancer in radiotherapy. | 03-26-2009 |
